[Therapy of Parkinson's syndrome].
D000547:Amantadine / Q000627:therapeutic use; D001545:Benserazide / Q000627:therapeutic use; D002230:Carbidopa / Q000627:therapeutic use; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy* / Q000628:therapy; D026741:Physical Therapy Modalities; D012110:Reserpine / Q000627:therapeutic use; D013238:Stereotaxic Techniques
D010276:Parasympatholytics; D007980:Levodopa; D001545:Benserazide; D012110:Reserpine; D000547:Amantadine; D002230:Carbidopa
Die Behandlung des Parkinson-Syndroms